Geode Capital Management LLC Takes Position in Astrana Health, Inc. (NASDAQ:ASTH)

Geode Capital Management LLC bought a new stake in Astrana Health, Inc. (NASDAQ:ASTH - Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The fund bought 1,018,018 shares of the company's stock, valued at approximately $58,995,000. Geode Capital Management LLC owned 1.81% of Astrana Health at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Barclays PLC purchased a new position in Astrana Health in the third quarter valued at $4,457,000. State Street Corp acquired a new stake in shares of Astrana Health during the 3rd quarter valued at about $91,966,000. Stifel Financial Corp purchased a new position in shares of Astrana Health in the 3rd quarter valued at about $800,000. QSV Equity Investors LLC acquired a new position in Astrana Health in the 3rd quarter worth about $1,715,000. Finally, Quarry LP purchased a new position in Astrana Health during the third quarter worth approximately $77,000. 52.77% of the stock is owned by hedge funds and other institutional investors.

Astrana Health Price Performance

Shares of NASDAQ:ASTH traded down $1.39 during midday trading on Friday, hitting $33.70. The company's stock had a trading volume of 1,050,296 shares, compared to its average volume of 217,520. The company has a market cap of $1.90 billion, a P/E ratio of 25.92, a price-to-earnings-growth ratio of 1.80 and a beta of 1.13. Astrana Health, Inc. has a 12-month low of $33.44 and a 12-month high of $63.20. The business's 50 day simple moving average is $47.22 and its 200 day simple moving average is $47.92. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.91 and a current ratio of 1.91.

Astrana Health (NASDAQ:ASTH - Get Free Report) last released its quarterly earnings data on Thursday, November 7th. The company reported $0.33 EPS for the quarter, meeting analysts' consensus estimates of $0.33. The company had revenue of $478.71 million during the quarter, compared to the consensus estimate of $462.01 million. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. During the same quarter in the prior year, the firm earned $0.47 EPS. On average, analysts forecast that Astrana Health, Inc. will post 1.16 EPS for the current year.

Analyst Ratings Changes

A number of analysts have recently commented on ASTH shares. BTIG Research boosted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a "buy" rating in a research report on Thursday, October 3rd. Macquarie raised shares of Astrana Health to a "hold" rating in a report on Monday, December 16th. KeyCorp initiated coverage on shares of Astrana Health in a research report on Friday, October 11th. They set a "sector weight" rating for the company. Robert W. Baird lifted their target price on shares of Astrana Health from $67.00 to $86.00 and gave the company an "outperform" rating in a research report on Wednesday, November 13th. Finally, TD Cowen began coverage on shares of Astrana Health in a research report on Monday, October 14th. They set a "buy" rating and a $66.00 price target for the company. Two research analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, Astrana Health currently has a consensus rating of "Moderate Buy" and an average price target of $65.17.

Astrana Health Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.